ALKS — AI Stock Analysis & Recommendation

TradeFlare's AI research teams rate ALKS a BUY. The current price is $39.73.

• Entry: $49.61

The current technical and fundamental picture for ALKS is mixed, warranting a cautious approach. Catalysts to watch: Positive developments in ALKS's CNS pipeline; Continued revenue growth from key CNS medicines; Favorable shifts in analyst sentiment. Key risks: Significant negative earnings growth and recent negative operating cash flow; High short interest and potential for volatility; Product concentration and R&D risks associated with clinical trials.

Last updated October 14, 2026 · AI-generated analysis for informational purposes, not financial advice.